Zentalis Pharmaceuticals (ZNTL) Income from Non-Controlling Interests (2019 - 2024)
Zentalis Pharmaceuticals (ZNTL) recorded Income from Non-Controlling Interests of -$28,000 in FY2024, compared with -$114,000 in FY2023.
Powered by 
Analysis
Zentalis Pharmaceuticals (ZNTL) Income from Non-Controlling Interests (2019 - 2024) Analysis & Trends
Starting with FY2019, Zentalis Pharmaceuticals' Income from Non-Controlling Interests history includes 6 years.
- The FY2024 figure is the highest annual Income from Non-Controlling Interests in data going back to FY2019.
- Per Business Quant data, ZNTL's Income from Non-Controlling Interests was -$114,000 in FY2023, -$307,000 in FY2022, -$7.37 million in FY2021 and -$707,000 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Zentalis Pharmaceuticals | 180.60 Mn | 180.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | -37,000.00 |
| Mar 31, 2023 | -43,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | -99,000.00 |
| Jun 30, 2022 | -35,000.00 |
| Mar 31, 2022 | -160,000.00 |
| Dec 31, 2021 | -36,000.00 |
| Sep 30, 2021 | -6.30 Mn |
| Jun 30, 2021 | -488,000.00 |
| Mar 31, 2021 | -543,000.00 |
| Dec 31, 2020 | -53,000.00 |
| Sep 30, 2020 | -110,000.00 |
| Jun 30, 2020 | -435,000.00 |
| Mar 31, 2020 | -109,000.00 |
| Dec 31, 2019 | -40,000.00 |
| Sep 30, 2019 | -228,000.00 |
| Jun 30, 2019 | -127,000.00 |
API Access
Zentalis Pharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ZNTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ZNTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ZNTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();